Aim: Lung cancer in elderly patients is an increasingly common problem for the oncology practioner. In spite of the fact that platinum-based doublets are considered the standard therapy for patients with advanced non-small-cell lung cancer (NSCLC), the best treatment for elderly patients is still debated. The aim of this retrospective single center study was to evaluate the clinical features and the efficacy of platinum-based therapy specifically for elderly patients with metastatic NSCLC. Methods: We retrospectively reviewed 48 metastatic NSCLC in patients aged 65 years or older, who were treated with platinum-based therapy as first-line treatment, from April 2007 to December 2012 in Hassan II University Hospital of Fez, Morocco.
